NCT01576588View on ClinicalTrials.gov

Rituximab in Pretreated Elderly or Unfit B-CLL Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

January 31, 2016

Study Completion Date

June 30, 2019

Conditions
B-Cell Chronic Lymphocytic Leukemia
Interventions
DRUG

Rituximab

Rituximab (Rtx) antibody infusions will be administered on Day 1, 2, 3 (cycle 1) and Day 1 (cycles 2 to 4).

DRUG

Glucocorticoid

Glucocorticoid (either Dexamethasone or Methyl-prednisolone) infusions will be administered on Days 1 to 3 (cycles 1-4(6)) and should precede the Rituximab infusion.

Trial Locations (1)

08661

Vilnius University Hospital Santaros Klinikos, Vilnius

All Listed Sponsors
lead

Prof. Dr. Med. Laimonas Griskevicius

OTHER

NCT01576588 - Rituximab in Pretreated Elderly or Unfit B-CLL Patients | Biotech Hunter | Biotech Hunter